Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Amir Mufaddel

Amir Mufaddel

Al Ain Hospital, UAE

Aysegul Firat

Aysegul Firat

Hacettepe University, Turkey

Amal Al Hashmi

Amal Al Hashmi

Vice President Oman Medical Association, Oman

Bo Feng

Bo Feng

University of Hong Kong, Hong Kong

David Allsop,

David Allsop,

University Lancaster, UK

David Borchelt

David Borchelt

University of Florida, USA

Christianto B. Lumenta

Christianto B. Lumenta

University of Munich, Germany

Alok Sharma

Alok Sharma

NeuroGen Brain & Spine Institute, India

Vascular Dementia Congress 2019

About Conference


Conference series llc LTD organizes conference series all around the world in 2018; here it is our pleasure to invite you to Neuroscience conference entitled 12th International Conference on Vascular Dementia during July 22-23, 2019, at London, UK.

In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer's disease and dementia with Lewy bodies. Vascular dementia symptoms may be most obvious when they happen soon after a major stroke includes confusion, disorientation, trouble speaking or understanding speech and vision loss.

Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly, however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The prevalence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.

The overall multi infarct dementia market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America held largest market share in terms of revenue owing to the increasing incidences of multi infarct dementia coupled with increasing geriatric population base. European market displayed similar traits and followed North American multi infarct dementia market. Asia Pacific is expected to grow at a high pace due to increasing awareness about prevention of brain strokes in this region. Japan owing to increased geriatric base represents approximately more than 50% of the dementia cases in Asia Pacific. The developed nations such as Japan, Canada, France, Germany and U.S. are anticipated to witness favourable growth over the forecast period.

Various companies in the multi infarct dementia market are adopting several economical strategies such as collaborations, expansions and acquisitions to keep a strong position and gain advantage in the market. Some major companies in the market include Forest Laboratories, Inc., Janssen Pharmaceuticals, Inc., Novartis Pharmaceutical Corporation, Pfizer, Inc. and Eisai, Inc.

Why to attend ?

Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

Target Audience

Business delegates, Industrial Leaders, Vascular Dementia Researchers, Neurologist, Neuroscientist

Sessions/Tracks

 Session 1: Dementia

Dementia is a chronic or persistent disorder of the mental ability process caused by brain diseases or injuries marked due to personality changes, memory disorders and impaired reasoning. Dementia is not a specific disease. It's a group of symptoms related with a decline in memory or other thinking ability skills enough to reduce a person's ability activities. Various kinds of dementia are associated with particular types of brain cell damage in particular regions of the brain

  • Memory
  • Communication and language
  • Ability to focus and pay attention
  • Reasoning and judgment
  • Visual perception

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology ConferencesAlzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia, July 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Lewy Body Dementia Association ; Parkinson Society Canada ; American Association of Neurological Surgeons ; American Academy of Neurology ;World Federation of Neurology ; Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International ; Association of Parkinsonism and Related Disorders ; World Federation of Neurology ; Alzheimer's Association and  Alzheimer's Foundation of America 

Session 2: Vascular Dementia

Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Thinking problems also may begin as mild changes that worsen gradually as a result of multiple minor strokes or other conditions that affect smaller blood vessels, leading to cumulative damage. Vascular dementia symptoms can vary widely, depending on the severity of the blood vessel damage and the part of the brain affected. Memory loss may or may not be a significant symptom depending on the specific brain areas where blood flow is reduced. Symptoms may be most obvious when they happen soon after a major stroke

  • Confusion.
  • Disorientation.
  • Trouble speaking or understanding speech.
  • Vision loss

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations : Acoustic Neuroma Association and ADA Disability and Business Technical Assistance Program ; Aicardi Syndrome Foundation and Alliance for Aging Research ; ALS Association and ALS Therapy Development Institute ; Alternating Hemiplegia of Childhood Foundation and Alzheimer's Drug Discovery Foundation ; Alzheimer's Association and Alzheimer's Foundation of America ; American Association on Health and Disability and American Autoimmune Related Diseases Association ; American Behcet's Disease Association and American Brain Coalition ; American Brain Tumor Association and American Cancer Society ; American Headache Society Committee for Headache Education and American Heart Association ; American Liver Foundation and American Parkinson Disease Association

Session 3: Alzheimers Disease

In Alzheimer's disease, high levels of certain proteins inside and outside brain cells make it hard for brain cells to stay healthy and to communicate with each other. The brain region called the hippocampus is the center of learning and memory in the brain, and the brain cells in this region are often the first to be damaged. That's why memory loss is often one of the earliest symptoms of Alzheimer's. While most changes in the brain that cause dementia are permanent and worsen over time, thinking and memory problems caused by various conditions

  • Depression
  • Medication side effects
  • Excess use of alcohol
  • Thyroid problems
  • Vitamin deficiencies

Related Conferences :  Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations:American RSD Hope Organization and American Sleep Apnea Association ; American Speech-Language-Hearing Association and American Stroke Association ; Attention Deficit Disorder Association and Autism National Committee ; Austin Network International and Autism Research Institute ; Autism Science Foundation and Autism Society of America ; Barth Syndrome Foundation Batten Disease Support and Research Association ; Brain  Aneurysm Foundation and Brain Injury Association of  AmericaBrain Injury Resource Center and Brain Trauma Foundation

Session 4: Dementia stages

Dementia in “stages,” refers how far a person’s dementia has been progressed. It defines a person’s disease stage helping physicians to determine the best treatment approach and aid communication between health providers and caregivers. Sometimes the stage is simply referred to as “early stage”, “middle stage” or “late-stage” dementia, but often a more exact stage is assigned, based on a person’s symptoms.

  • Global Deterioration Scale for Assessment of Primary Degenerative Dementia (GDS)
  •  Cognitive Decline
  •  Very Mild Cognitive Decline
  •   Mild Cognitive Decline
  • Moderate Cognitive Decline
  • Moderately Severe Cognitive Decline
  • Severe Cognitive Decline (Middle Dementia)
  • Very Severe Cognitive Decline (Late Dementia)
  • Functional Assessment Staging (FAST)
  • Clinical Dementia Rating (CDR) – No dementia, Moderate, Mild , Severe.

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia, July  22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Caregiver Action Network and Carter Center for Brain Research in Holoprosencephaly ; Cerebral Palsy Foundation and CHADD ; Childhood Brain Tumor Foundation ; Children’s Brain Disease Foundation and Children’s Brain Tumour Foundation ; Children's Brain Disease Foundation and Children's Brain Tumor Foundation ; Lewy Body Dementia Association ; Lowe Syndrome Association

Session 5: Dementia with Lewy Body (DLB)

People with Lewy body dementia have a progressive decline in their memory and ability to think; similar to Alzheimer’s disease. However, the cognitive ability or alertness of a person with Lewy body dementia is more likely to fluctuate from one moment to the next, which is not like Alzheimer’s disease. They also often have visual hallucinations (seeing things that aren’t there) and delusions (believing something that is not true). On the surface, people with Lewy body dementia often have problems with movement that resemble Parkinson’s disease. This is because the same structures of the brain are affected in Lewy body dementia and Parkinson’s disease.

  • Causes of Lewy Body Dementia
  • Symptoms of Lewy Body Dementia
  • Diagnosing Lewy Body
  • Dementia Cholinesterase Inhibitors
  • Diagnosing dementia (general)
  • Treating dementia

Related Conferences :Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Christopher and Dana Reeve Foundation ; Coma/Traumatic Brain Injury Recovery Association and Compassionate Friends ; Epilepsy Foundation and Epilepsy Institute ; Fibromuscular Dysplasia Society of America and Fibromyalgia Network ; Hereditary Disease Foundation and Hereditary Neuropathy Foundation, Inc ; Huntington's Disease Society of America ; International Radio Surgery Association ;Intractable Childhood Epilepsy Alliance ; Jain Foundationand John Douglas French Alzheimer's Foundation ; Learning Disabilities Association of America and Les Turner ALS Foundation

Session 6 : Neurodegenerative Diseases

Neurodegenerative disease primarily affects the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias). Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases.

  • Alzheimer’s disease (AD) and other dementias
  • Parkinson’s disease (PD) and PD-related disorders
  • Prion disease
  • Motor neurone diseases (MND)
  • Huntington’s disease (HD)
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)

Related Conferences :Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations:Lupus Foundation of America and Lupus Research Institute ; Michael J. Fox Foundation for Parkinson's Research ; Migraine Research Foundation ; Multiple Sclerosis Association of America and Multiple Sclerosis Foundation ;Multiple System Atrophy Coalition and MUMS National Parent to Parent Network ; Brain Tumor Research and Information ; Myelin Repair Foundation and Myositis Association

Session 7 : Brain Diseases

The brain is the control center of the body. It controls thoughts, memory, speech, and movement. It regulates the function of many organs. When the brain is healthy, it works quickly and automatically. However, when problems occur, the results can be devastating. Inflammation in the brain can lead to problems such as vision loss, weakness and paralysis. Loss of brain cells, which happens if you suffer a stroke, can affect your ability to think clearly. Brain tumors can also press on nerves and affect brain function. Some brain diseases are genetic. And we do not know what causes some brain diseases, such as Alzheimer's disease.

  • Hematomas
  • Seizures
  • Huntington’s disease
  • ALS (amyotrophic lateral sclerosis), or Lou Gehrig’s disease
  • Parkinson’s disease
  • Depression
  • Bipolar disorder
  • Post-traumatic stress disorder (PTSD)
  • Schizophrenia

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: National Multiple Sclerosis Society ; National Parkinson Foundation ; National Patient Travel Center and National Rehabilitation Information Center ;National Respite Network and Resource Center and National Reye's Syndrome Foundation ; National Shingles Foundation and National Sleep Foundation ; National Spasmodic Dysphonia Association and National Spasmodic Torticollis Association ; National Spinal Cord Injury Association and National Stroke Association

Session 8 : Parkinson Disease Dementia

Parkinson's disease (PD) is an age-related degenerative disorder of certain brain cells. It mainly affects movements of the body, but other problems, including dementia, may occur. It is not considered a hereditary disease, although a genetic link has been identified in a small number of families. Depression, anxiety, personality and behavior changes, sleep disturbances, and sexual problems are commonly associated with Parkinson's disease. In many cases, Parkinson's disease does not affect a person's ability to think, reason, learn, or remember (cognitive processes).

  • Depression
  • Cardiovascular disease
  • Anxiety
  • Psychosis

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Rehabilitation International and Research Center for Stroke ;  Spastic Paraplegia Foundation and Spina Bifida Association ;Spinal Cord Society and Spinal Muscular Atrophy Foundation ; United Brachial Plexus Network and United Cerebral Palsy ;United Leukodystrophy Foundation and United Mitochondrial Disease Foundation

Session 9 : Neuropharmacology

Neuropharmacology is the scientific study of the effects of drugs on the nervous system. Its primary focus is the actions of medications for psychiatric and neurologic disorders as well as those of drugs of abuse. Drugs that act on the nervous system, including antidepressant, antianxiety, anticonvulsant, and antipsychotic agents, are among the most widely prescribed medications.

  • Pharmacogenomics
  • Pharmacoepidemiology
  • Toxicology
  • Posology
  • Pharmacognosy
  • Behavioral Pharmacology

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations:  NBIA Disorders Association and Neurofibromatosis Network ; Neuropathy Association and Nevus Outreach , Inc ; Parent Project Muscular Dystrophy and Parkinson Alliance ; Parkinson's Action Network and Parkinson's Disease Foundation ; Parkinson's Institute and Clinical Center and Parkinson's Resource Organization ; Pituitary Network Association and PMD Foundation ; Project ALS and Pseudo tumor Cerebri Support Network

Session 10 : Neuro Oncology and CNS

Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are among the many examples of these). Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma are among the worst.

The CNS consists of the brain and spinal cord. The brain is protected by the skull (the cranial cavity) and the spinal cord travels from the back of the brain, down the center of the spine, stopping in the lumbar region of the lower back. The brain and spinal cord are both housed within a protective triple-layered membrane called the meninges.

  • Brain Stem Tumors
  • Spine Diseases
  • Glioblastoma
  • Meningioma
  • Malignant Brain Cancers and Brain Metastasis
  • Pediatric Neuro Oncology
  • Astrocytoma
  • Neurotoxicity

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: United Spinal Association and Vascular Birthmarks Foundation ; Williams Syndrome Association and Wilson Disease Association ; World Health Organization ; National Aphasia Association ; National Association of Hospital ; National Headache Foundation and National Health Council ; National Hospice and Palliative Care Organization and National Hydrocephalus Foundation ; National Meningitis Association and National MPS Society , Inc

Session 11 : Vascular Cognitive Impairment

Vascular cognitive impairment is a decline in thinking abilities caused by disease that damages the brain’s blood vessels. Vascular disease may cause cognitive impairment on its own, and can also contribute to impairments in thinking and behaviour in a person with another brain disease such as

Alzheimer’s.

  • Small vessel disease
  • Ischaemic stroke
  • Haemorrhagic stroke
  • Stroke and vascular cognitive impairment

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Lewy Body Dementia Association ; Parkinson Society Canada ;  American Association of Neurological Surgeons ; American Academy of Neurology ; World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology ; Alzheimer's Association and  Alzheimer's Foundation of America 

Session 12: Dementia Care Management

Treatment of dementia depends on its cause. In the case of most progressive dementias, including Alzheimer's disease, there is no cure and no treatment that slows or stops its progression. But there are drug treatments that may temporarily improve symptoms. The same medications used to treat Alzheimer's are among the drugs sometimes prescribed to help with symptoms of other types of dementias. Non-drug therapies can also alleviate some symptoms of dementia.

  • Psychopharmacological treatment
  • Psychopharmacological treatment
  • Advanced drugs for dementia
  • Cognitive behavioral therapy
  • Family therapy in nursing

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Lewy Body Dementia Association ; Parkinson Society Canada ;  American Association of Neurological Surgeons ; American Academy of Neurology ; World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology ; Alzheimer's Association and  Alzheimer's Foundation of America 

Session 13: Dementia Nursing

People with Dementia and vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects aphasia, apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities. Furthermore, people with dementia commonly experience the ill effects of comorbid conditions that extra confuse mind and block best results. Along these lines, creating caregiving techniques individuals with vascular dementia is pressing, given this expanding commonness and consequently the related weight that dementia places not just on the people, however on the parental figures, relations, and thusly the assets of the human services framework. Traditional perspectives bearing on geriatric nursing ordinarily paint a picture of the care as being moderate paced certain and less requesting than intense care. Be that as it may, care of the matured, and especially those with vascular dementia, is normally confounded, unusual, and flimsy.

  • Dementia nursing care plan
  • Music therapy in dementia
  • Physiotherapy for dementia
  • Clinical features of dementia
  • Therapeutic interventions in dementia

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia 22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Lewy Body Dementia Association ; Parkinson Society Canada ;  American Association of Neurological Surgeons ; American Academy of Neurology ; World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology ; Alzheimer's Association and  Alzheimer's Foundation of America 

Session 14 : Therapeutic Targets

Therapeutic targets are bio molecules maybe a nucleic acid or a protein whose biological activity can be modified by a drug candidate. In some cases of Dementia, it is reported that proteins are the cause for the disease. For example the accumulation of amyloid protein in the regions of Brain acts as a major factor for the disorder, hence it can be a therapeutic target . Therapeutic targets play an important role in identifying the potential drug candidates . Hence the conference provides the discussion sessions to reveal the targets for drug design process.

  • Beta-amyloid Precursor Protein
  • Action of Protein tau
  • Role of Acetylcholinesterase and Inhibition
  • N-methyl-d-aspartate (NMDA) receptor as target
  • Processing of Prion Protein

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia,  22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Lewy Body Dementia Association ; Parkinson Society Canada ;  American Association of Neurological Surgeons ; American Academy of Neurology ; World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology ; Alzheimer's Association and  Alzheimer's Foundation of America 

Session 15 : Clinical Trials and Drug Development

Rigorous clinical trials on Dementia drugs are continuing in USA and UK under the guidance of Alzheimer's society and it is reported that there is very less participation of people. The most of drugs are in second and third phases. Most of clinical trials are done in specific areas are amyloid beta plaques, the immune system, tau tangles. New medications for Dementia being developed in 2014/2015, 31% were named symptoms modifying. There are many developments are going on in Drug discovery of Dementia as old treatments are unable to stop the progression of Dementia. Most associations share their exploration on new medications for Dementia in Dementia conferences to get higher esteem to their items. This gets to be distinctly gainful to different geriatric doctors to redesign themselves with such medications and progressing possibilities by going to Dementia conferences. Such Dementia meetings will help researchers to know target areas for Drug development in Dementia and work towards it and also Dementia conferences exhibit clinical trial medications and offers positivity to discover new approaches in curing Dementia

  • Development of Re-purposed Drugs
  • Beta-amyloid Polymerization and Inflammation Inhibitor
  • Prevention Trials
  • Anticonvulsant Drugs for Treatment
  • Vaccine Development against Beta-Amyloid
  • Animal Models for Toxicology Studies

Related Conferences : Alzheimer's Conferences | Dementia care conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conferences | Alzheimer’s and Dementia Care Conferences | Neuroscience Conferences | Dementia Treatment Conferences | Dementia Lewy bodies Conferences | Epilepsy Conferences | Parkinson Conferences | Psychology Conferences | Neuropathology Conferences | Experimental Neurology Conferences | Neurosurgery Conferences | Clinical Nuclear Medicine Conferences | Internal Medicine Conferences |  Neuro Chemistry Conferences | Cognitive Rehabilitation Conferences

12th International Conference on Vascular Dementia,  22-23, 2019, London, UK, 4th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland, 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria, 2nd International Conference on Epilepsy and Treatment, October 20-21, 2018 Rome, Italy, Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology, Germany, 9th International Symposium on Neuroprotection and Neurorepair 2018,Germany, 12th Congress of the European Association of Neuro-Oncology, Germany.

Related Associations: Lewy Body Dementia Association ; Parkinson Society Canada ;  American Association of Neurological Surgeons ; American Academy of Neurology ; World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ; Association of Parkinsonism and Related Disorders  ; World Federation of Neurology ; Alzheimer's Association and  Alzheimer's Foundation of America 

 

Market Analysis

Vascular Dementia 2019  welcomes attendees, exhibitors and presenters all over the world to our conference venue London, UK. We will be delighted to invite you all attending for “12 th International Conference on Vascular Dementia” that would be held during July 22-23, 2019 London, UK, with the theme: New and Emerging Target Therapies in Vascular Dementia.

Dementia is general term for memory misfortune and other intellectual capacities sufficiently genuine to meddle with everyday life. Alzheimer's illness represents 60 to 80 % of dementia cases.

This gathering will build information, offer help, help learning and enable families and carers to search out relevant administrations for their adored one and to build up the most ideal home condition to help recuperation from this mind boggling and decimating maladies.

Alzheimer's disease is the most common form of dementia. The proportions of those with different forms of dementia can be broken down as follows:

Alzheimer's disease: 62%

Vascular dementia: 17%

Mixed dementia: 10%

Lewy-body dementia: 4%

Fronto-temporal dementia: 2%

Parkinson's dementia: 2%

Other: 3%

Why to attend???

According to WHO 47.5 million people have dementia and every year 7.7 million new cases are appearing. By 2030 total cases of dementia is projected to be 75.6 million and almost triple by 2050 to 135.5 million. Alzheimer’s disease contributes 60-70 % of cases in dementia and second most common condition of dementia is vascular dementia which contributes 20% of cases all over the world. Total estimated cost of dementia is 818 billion US $ in 2015.

With members from around the world focused on learning about various Alzheimer’s disease and how to prevent the disorders. This is your best opportunity to reach the largest assemblage of participants from the entire world.

At the Dementia conferences and from the eminent people speech, you can update your knowledge about current situation of Dementia  research and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Dementia fields are hallmarks of this conference.

Importance and Scope:

The treatment for global market in evaluation of syndromes for vascular dementia, with the movement disorders values are of range 10.5 billion in 2011 that reach $11.1 billion in 2012. Total market value that is expected to reach $16.7 billion in 2017 with raise at a five-year compound annual growth rate (CAGR) of 8.5%.

From every corner of the world, someone develops dementia every 3 seconds. This was an estimated value at 46.8 million people worldwide living with dementia in 2015 and the number is expected to be close to 50 million people in 2017. This number may double every 20 years, reaching 75 million in 2030 and 131.5 million in 2050. Mostly it is observed too be increased in developing countries. For now, 58% of people with dementia are living in low and middle income countries, may be, by 2050 this can rise to 68%.

Worldwide results of current meta-analysis reveal 44 million people (worldwide) suffered with Vascular dementia during 2010 and expected to double every 20 years, to the number 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 per cent of all people with low or middle incomes were with dementia lived in countries. This proportion anticipated in increase to 63 per cent in 2030 and 71 per cent in 2050.The values are expected to double by 2030 and triple by 2050 to 115 million.The survey reveals in United States, an estimate of many as five million people age 65 and older suffer from Alzheimer’s disease. 

Vascular Dementia is most widely considered to be the second common cause of Alzheimer's disease, accounting for 10 % of cases. Many experts believe vascular dementia remains less diagnosed for Alzheimer's disease, even the disease is common.

Alzheimer's Research UK at present funds 150 research projects across UK and focusing on developing stages which has been committed nearly £40million to dementia research.

Their research focus is on improvement of the quality of life already living with Alzheimer’s disease and also other forms of dementia.

Vascular Dementia 2019 provides a good platform where everyone will be sure having a meaningful experience with scholars, experts across the globe. The members of Vascular Dementia 2019 wishes meeting you in London, UK.

Why London?

London is the capital and most crowded city of England and the United Kingdom. Remaining on the River Thames in the south east of the island of Great Britain, London has been a noteworthy settlement for two centuries. It was established – most likely proximate to an as of now subsisting Celtic Briton town or settlement – around the year 43 by the Romans, who assigned it Londinium. London’s age-old center, the City of London, to a great extent holds its 1.12-square-mile (2.9 km2) medieval limits. Since at any rate the nineteenth century, “London” has furthermore alluded to the city around this center, truly part between Middlesex, Essex, Surrey, Kent, and Hertfordshire, which today to a great extent makes up More prevalent London, represented by the Mayor of London and the London Assembly.

London is the leading global city in arts, commerce, finance, fashion, education technology, healthcare, media, transport, tourism, research, and development. London is the global centre for Higher Education and research. According to QS World University Ranking, it has the highest number of international students. It is world’s second most Economical powerful city and has the fifth- or sixth-largest metropolitan area GDP in the world. London is the world’s leading investment destination, which hosts more number of international retailers and ultra-high-net-worth individuals. It has world’s largest city Airport System measured by passenger traffic.

Conference Highlights

Dementia

Vascular Dementia

Alzheimers Disease

Dementia stages

Dementia with Lewy Body (DLB)

Neurodegenerative Diseases

Brain Diseases

Parkinson Disease Dementia

Neuropharmacology

Neuro Oncology and CNS

Vascular Cognitive Impairment

Dementia Care Management

Dementia Nursing

Therapeutic Targets

Clinical Trials and Drug Development

Funding Projects

·         Alzheimer’s Research UK

·         Alzheimer's Association

·         Alzheimer's Disease Education and Referral Center (ADEAR)

·         National Institute on Aging

·         Alzheimer's Foundation of America

·         Alzheimer’s Drug Discovery Foundation

·         Association for Frontotemporal Degeneration (AFTD)

·         BrightFocus Foundation

·         John Douglas French Alzheimer's Foundation

·         Lewy Body Dementia Association

·         National Institute of Mental Health (NIMH)

·         National Organization for Rare Disorders (NORD)

·         BRACE - Alzheimer's Research

·         Alzheimer's Society

·         Alzheimer's Society of Canada

Target Audience

·         Directors

·         Head of Department

·         Professors

·         Industrial

·         Neurologist

·         Neuroscientist

·         Neurosurgeons

·         Psychiatrist

·         Nutritional Scientists

·         Students from Academia in the research of Neurology, Nutrition

Top universities 500 globally working in the field of Vascular Dementia.

·         Harvard University

·         University College London

·         University of California--San Francisco

·         Stanford University

·         Massachusetts Institute of Technology

·         Johns Hopkins University

·         University of California--Los Angeles

·         University of California--San Diego

·         Columbia University

·         University of Oxford

·         University of Cambridge

·         Yale University

·         University of Pennsylvania

·         University of Toronto

·         Washington University in St. Louis

·         New York University

·         McGill University

·         King's College London

·         Karolinska Institute

·         California Institute of Technology

Top Hospitals Associated with Vascular Dementia Research in World.

·         John Hopkins Medicine

·         Massachusetts General Hospital

·         Siloam Hospitals

·         Mayo Clinic

·         The Mount Sinai Hospital

·         Jefferson Hospital for Neuroscience

·         Neurology Florida Hospital

·         UNM Neurology Centre

·         Tampa General Hospital

·         Huntington Hospital

·         EI Camino Hospital

There are above 500 Companies Associated with Vascular Dementia Research in World.

·         Forest Laboratories

·         Janssen Pharmaceuticals

·         Novartis Pharmaceutical Corporation

·         Pfizer

·         Eisai

·         Actinogen Limited

·         Alector LLC

·         AlzProtect SAS

·         TauRx Therapeutics Ltd

·         Pacific Northwest Biotechnology

·         Tautatis Incorporated

Past Conference Report

Vascular Dementia Congress 2018

Vascular Dementia 2018

The 11th International conference on Vascular Dementia hosted by Conference Series llc LTD took place at Moscow, Russia during July 23-25, 2018.

Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series llc LTD Journals as well as from eminent scientists, talented researchers and young student community.

Researchers and students who attended from different parts of the world have made the conference one of the most successful and productive events in 2019 from Conference Series llc LTD.

The conference was marked by the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought-provoking keynote and plenary presentations highlighting the theme “Integrating Recent Discoveries and Interpreting Vascular Dementia Research for Better Health”

Conference Series llc LTD has taken the privilege of felicitating Vascular Dementia 2018 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

Conference Series llc LTD, on behalf of the conference sponsor, appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavours.

The esteemed guests, Keynote speakers, well-known researchers, and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Vascular Dementia 2019 Conference.

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series llc LTD “Journal of Alzheimer’s Disease & Parkinsonism” as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums.

We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Vascular Dementia 2018.

With the unique feedbacks from the conference, Conference Series llc LTD would like to announce the commencement of the 12th  International Conference on Vascular Dementia during  22-23, 2019 London, UK

Let us meet again @ Vascular Dementia 2019

 

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 22-23, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders Brain Disorders & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos